Validation and Modification of Renal Risk Score for Prediction of Long-Term Kidney Survival in Patients with MPO-ANCA-associated Glomerulonephritis

Meng Yang,Xia Liu,Yinghua Chen,Xin Chen,Feng Xu,Zhengzhao Liu,Haitao Zhang,Caihong Zeng,Weixin Hu
DOI: https://doi.org/10.1007/s40620-024-02134-z
IF: 4.4061
2024-01-01
Journal of Nephrology
Abstract:Anti-neutrophil cytoplasmic antibody (ANCA) Renal Risk Score has not been widely validated in Chinese patients with myeloperoxidase -ANCA-associated glomerulonephritis and its predictive ability needs to be improved. Three hundred and forty patients with biopsy-proven myeloperoxidase-ANCA-associated glomerulonephritis were included in this study. They were divided into an oliguric group (urine volume < 400 ml/24 h) and a non-oliguric group (urine volume ≥ 400 ml/24 h). The ANCA Renal Risk Score and Berden classes were used to predict the risk of end-stage kidney disease (ESKD), and Cox regression analysis was performed to evaluate the impact of oliguria on ESKD risk. The predictive performance of ANCA Renal Risk Score was significantly higher than that of Berden classes (AUC: 0.79 vs. 0.709, P = 0.003). Thirty-six (10.6
What problem does this paper attempt to address?